Originally published by our sister publication Gastroenterology & Endoscopy News
BOSTON—Therapeutic exposure to aspirin and nonsteroidal anti-inflammatory drugs is associated with a lower risk for cancer, including liver cancer, and decreased mortality risk in people with liver disease, according to new research.
To investigate the effect of exposure to aspirin and NSAIDs in patients with chronic liver disease, researchers from the Karolinska Institutet in Sweden conducted a